NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Attention Disorders


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Addrenex Pharmaceuticals Acquired by Sciele Pharma
2009 NOV 30 ... Sciele previously licensed three products from Addrenex, including Clonicel for attention deficit hyperactivity disorder (ADHD) and Jenloga XR (once-daily clonidine) for ... to explore the impact that neurotransmitter regulation has on a variety of diseases and disorders. Addrenex identified adrenergic regulation as its initial research focus. Adrenergic ...
Subject: Tics
Price: $3.00
*
Alkermes Announces Positive Results from Phase 3 Clinical Study of Naltrexone for Extended-Release Injectable Suspension for the Treatment of Opioid Dependence
2009 NOV 30 ... Patients should be warned of the risk of hepatic injury and advised to seek medical attention if they experience symptoms of acute hepatitis. Use of VIVITROL should be discontinued ... for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has ...
Subject: Alkermes, Inc.
Price: $3.00
*
Depression as deadly as smoking, but anxiety may be good for you
2009 NOV 30 ... don't know how causal the association with depression is but it does suggest that more attention should be paid to this link because the association persisted after adjusting for many ... a variety of adverse physical health outcomes and poor health associated with mental disorders such as depression and psychotic disorders. In light of the findings, Dr ...
Subject: King's College London
Price: $3.00
*
Findings from Tilburg University advance knowledge in neuroscience
2009 NOV 30 ... is lower than 20. Why then have whole bodies and bodily expressions not attracted the attention of researchers so far? The goal of this article is to contribute some elements for an ... "These experimental studies complement decades of reports on affective disorders in neurological patients and clinical studies of psychiatric populations. The most ...
Subject: Neuroscience
Price: $3.00
*
Findings in post-traumatic stress disorder in women reported from University of California, Department of Psychiatry
2009 DEC 1 ... "We speculate that the cognitive slowing seen in PTSD may be attributable to reduced attention due to a need to allocate resources to cope with psychological distress or unpleasant ... Fresh data on post-traumatic stress disorders are presented in the report 'Cognitive impairment and functioning in PTSD related to ...
Subject: Post-Traumatic Stress Disorders
View Free
Daily News
Article
Full recovery now possible for an 'untreatable' mental illness
2009 NOV 30 ... by many clinicians in the United States, Europe, and Asia, the therapy came to the attention of researchers in the Netherlands who were developing a large-scale study of treatments ... Illness, Mental Health, Mental Illness, Narcissistic Personality Disorder, Personality Disorders, Psychology, Psychotherapy, Quality of Life, Schizophrenia, Self-Injurious Behavior, ...
Subject: International Society of Schema Therapy
Price: $3.00
*
New psychiatry findings from University of Marburg described
2009 NOV 28 ... G72 status influenced a number of cognitive functions, such as verbal working memory, attention, and, at a trend level, spatial working memory and executive functions. Interestingly, ... from Marburg, Germany, "In the last years, several susceptibility genes for psychiatric disorders have been identified, among others G72 (also named D-amino acid oxidase activator, ...
Subject: Psychiatry
Price: $3.00
*
New psychiatry research from M. Rivalan and colleagues discussed
2009 NOV 30 ... Iowa Gambling Task (IGT), can be profoundly impaired in psychiatric disorders, such as attention-deficit/hyperactivity disorder, drug addiction, and also in healthy individuals for whom ...
Subject: Psychiatry
Price: $3.00
*
New research on anxiety disorders risk factors from University of Sydney summarized
2009 NOV 30 ... worry as an under-recognized phenomenon and one in need of further clinical and research attention." Phillips and colleagues published their study in Archives of Women's ... to 12 months were interviewed for current and lifetime history of depression and anxiety disorders using the SCID-I and completed a range of self-report measures measuring psychological ...
Subject: Anxiety Disorders Risk Factors
View Free
Daily News
Article
Piedmont Triad, N.C., biotech news/Targacept Presents Data from Highly Successful Phase 2b Trial of TC-5214 as Augmentation Treatment for Major Depressive Disorder
2009 NOV 30 ... has clinical-stage product candidates in development for major depressive disorder, attention deficit/hyperactivity disorder, Alzheimer's disease and cognitive dysfunction in ... a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept's product candidates selectively modulate neuronal nicotinic receptors that ...
Subject: Selective Serotonin Reuptake Inhibitor
Price: $3.00
*
QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
2009 NOV 30 ... pain following bunionectomy and total knee replacement. These results have attracted the attention of investors and potential strategic partners." Rights Issue ... and commercialisation of therapies for pain management and central nervous system (CNS) disorders. Based on a business strategy to expand the clinical utility and commercial value of ...
Subject: Clinical Trial Research
Price: $3.00
*
Reports from University Hospital highlight recent research in schizophrenia therapy
2009 NOV 30 ... & React Testsystem and the Wiener Testsystem measuring visual perception, reaction time, attention, vigilance and stress-tolerance. Besides, patients underwent various driving simulations ... in psychomotor measures were most pronounced in concentration and vigilance. As mental disorders itself pose an increased risk of accidents, counselling patients with respect to ...
Subject: Schizophrenia Therapy
Price: $3.00
*
Reports outline posttraumatic stress disorder study findings from National Center for PTSD
2009 NOV 30 ... longitudinal study, each participant completed baseline measures of memory, executive attention, and response inhibition, and baseline and post-deployment self-report measures of PTSD ... Keywords: United States, Boston, Neuropsychology, Post-Traumatic Stress Disorders, Posttraumatic Stress Disorder. This article was prepared by Mental Health ...
Subject: Posttraumatic Stress Disorder
View Free
Daily News
Article
Research conducted at Temple University has updated our knowledge about behavior
2009 NOV 30 ... food and drug self-administration behavior. Although cannabinoid drugs have received attention as pharmacotherapeutics for various disorders, including obesity and addiction, it is ...
Subject: Behavior
Price: $3.00
*
Research from C. Huyard et al has provided new information about sociology of health and illness
2009 NOV 26 ... structure of so-called 'patients' organisations' has been accorded relatively little attention with respect to their increasing role in the medical world. This comparative study in ... world. This comparative study in France of eight such organisations, matching six rare disorders, explores the issue of power and decision making through the description of the entities ...
Subject: Sociology of Health and Illness
Price: $3.00
*
Residential Design for Persons with Neurological Disability: Special Issue of NeuroRehabilitation Unique Source of Design Perspectives, Insights and Practical Information
2009 NOV 30 ... design factors are often either ignored or minimally considered. This unique issue calls attention to the important topic of community-based residential designs for persons with ... cord injury, traumatic brain injury, neuromuscular disease, and other neurological disorders. Information is intended for an interdisciplinary audience. Issues of the journal are ...
Subject: Neurorehabilitation
Price: $3.00
*
Scientists at University of Minnesota target endocrinology
2009 DEC 2 ... Building a pediatric weight management program which achieves these goals requires attention to several aspects, including location, personnel, equipment, institutional support, ... Edwards and colleagues published their study in Reviews in Endocrine & Metabolic Disorders (Designing and implementing an effective pediatric weight management program. Reviews in ...
Subject: Endocrinology
Price: $3.00
*
Studies from University of Minnesota further understanding of attention deficit hyperactivity disorder
2009 NOV 30 ... twins, we conducted telephone screening interviews for parent-reported symptoms of attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) as well as indications ... Study (MTFS) by oversampling 11-year-old twins at especially high risk for substance use disorders by virtue of having a childhood disruptive disorder. The sample was ascertained from ...
Subject: Attention Deficit Hyperactivity Disorder
Price: $3.00
*
Study examines challenges of diagnosing neurofibromatosis type 1-like syndrome
2009 NOV 30 ... The study included 23 unrelated probands (first affected family member who seeks medical attention for a genetic disorder) carrying a SPRED1 mutation identified through clinical testing, ... to the media at www.jamamedia.org) Keywords: Bone, Diagnostics, Genetic Disorders, Genetics, Neurofibromatoses, Neurofibromatosis Type 1, Pediatrics, Psychological, ...
Subject: JAMA and Archives Journals
Price: $3.00
*
Study results from Duke University in the area of posttraumatic stress disorder in children published
2009 NOV 30 ... domains of fine-motor skills, language, visual-spatial, memory/learning, and attention/executive functions in two groups of nonsexually abused medically healthy neglected ... Durham, Clinical Trial Research, Neuropsychology, Pediatrics, Post-Traumatic Stress Disorders, Posttraumatic Stress Disorder, Therapy, Treatment. This article was ...
Subject: Posttraumatic Stress Disorder
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login